| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (oxacillin-susceptible) |
>0.25 |
>8 |
? － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin)  |
39 |
| Staphylococcus aureus (oxacillin-susceptible) |
>0.25 |
>16 |
? － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
403 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.5 |
0.5 |
0.25 － 0.5 |
Tigecycline (GAR-936, Tigacyl) |
476 |
| Staphylococcus aureus (oxacillin-susceptible) |
≤0.5 |
≤0.5 |
≤0.5 － >2 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
462 |
| Staphylococcus aureus (oxacillin-susceptible) |
≤0.5 |
≤0.5 |
≤0.5 － >2 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
412 |
| Staphylococcus aureus (oxacillin-susceptible) |
≤0.5 |
≤0.5 |
≤0.5 － 4 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
265 |
| Staphylococcus aureus (oxacillin-susceptible) |
≤0.5 |
≤0.5 |
≤0.5 － >8 |
Imipenem |
412 |
| Staphylococcus aureus (oxacillin-susceptible) |
≤0.5 |
≤0.5 |
? － ? |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
39 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.5 |
1 |
0.12 － 64 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
476 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.5 |
1 |
0.25 － 2 |
Oritavancin (LY333328) |
43 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.5 |
1 |
? － ? |
Amoxicillin-clavulanic acid (Augmentin) |
403 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.5 |
1 |
? － ? |
Cefprozil (Cefzil) |
403 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.5 |
1 |
? － ? |
Cefuroxime axetil (Ceftin) |
403 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.5 |
2 |
0.12 － 4 |
Teicoplanin (Targocid) |
43 |
| Staphylococcus aureus (oxacillin-susceptible) |
>0.5 |
>8 |
0.25 － >8 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
496 |
| Staphylococcus aureus (oxacillin-susceptible) |
>0.5 |
>8 |
? － ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
403 |
| Staphylococcus aureus (oxacillin-susceptible) |
>0.5 |
>16 |
≤0.12 － >16 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
18 |
| Staphylococcus aureus (oxacillin-susceptible) |
1 |
1 |
0.06 － 8 |
Amoxicillin-clavulanate |
493 |
| Staphylococcus aureus (oxacillin-susceptible) |
1 |
1 |
≤0.12 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
412 |
| Staphylococcus aureus (oxacillin-susceptible) |
1 |
1 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
265 |
| Staphylococcus aureus (oxacillin-susceptible) |
1 |
1 |
0.5 － 4 |
Cefuroxime (Kefurox, Zinacef) |
267 |
| Staphylococcus aureus (oxacillin-susceptible) |
≤1 |
≤1 |
≤1 － ? |
Imipenem |
462 |
| Staphylococcus aureus (oxacillin-susceptible) |
1 |
1 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
126 |
| Staphylococcus aureus (oxacillin-susceptible) |
1 |
1 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
39 |
| Staphylococcus aureus (oxacillin-susceptible) |
1 |
2 |
0.12 － 2 |
LBM415 (NVP-PDF-713, VIC-10495) |
265 |
| Staphylococcus aureus (oxacillin-susceptible) |
1 |
2 |
≤0.12 － 64 |
Zosyn |
412 |
| Staphylococcus aureus (oxacillin-susceptible) |
1 |
2 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
43 |
| Staphylococcus aureus (oxacillin-susceptible) |
1 |
2 |
1 － 4 |
Cefaclor (Ceclor, Ceclor CD) |
267 |